Niagen Bioscience Investor Relations Material
Latest events
Q1 2025
Niagen Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Niagen Bioscience Inc
Access all reports
ChromaDex Corporation is a biosciences company that develops and markets ingredients and consumer products based on nicotinamide riboside and other proprietary compounds. Its product portfolio supports healthy aging and cellular health, distributed through e-commerce and retail. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Key slides for Niagen Bioscience Inc
Corporate Presentation
Niagen Bioscience Inc
Q4 2024
Niagen Bioscience Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NAGE
Country
🇺🇸 United States